192 related articles for article (PubMed ID: 35031565)
1. CD169
Camara A; Lavanant AC; Abe J; Desforges HL; Alexandre YO; Girardi E; Igamberdieva Z; Asano K; Tanaka M; Hehlgans T; Pfeffer K; Pfeffer S; Mueller SN; Stein JV; Mueller CG
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031565
[TBL] [Abstract][Full Text] [Related]
2. Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone.
Habbeddine M; Verthuy C; Rastoin O; Chasson L; Bebien M; Bajenoff M; Adriouch S; den Haan JMM; Penninger JM; Lawrence T
Cell Rep; 2017 Nov; 21(9):2515-2527. PubMed ID: 29186688
[TBL] [Abstract][Full Text] [Related]
3. Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche.
Camara A; Cordeiro OG; Alloush F; Sponsel J; Chypre M; Onder L; Asano K; Tanaka M; Yagita H; Ludewig B; Flacher V; Mueller CG
Immunity; 2019 Jun; 50(6):1467-1481.e6. PubMed ID: 31201093
[TBL] [Abstract][Full Text] [Related]
4. CD169 mediates the capture of exosomes in spleen and lymph node.
Saunderson SC; Dunn AC; Crocker PR; McLellan AD
Blood; 2014 Jan; 123(2):208-16. PubMed ID: 24255917
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
6. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
8. The identification and developmental requirements of colonic CD169⁺ macrophages.
Hiemstra IH; Beijer MR; Veninga H; Vrijland K; Borg EG; Olivier BJ; Mebius RE; Kraal G; den Haan JM
Immunology; 2014 Jun; 142(2):269-78. PubMed ID: 24883436
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional heterogeneity of CD169⁺ and CD163⁺ macrophages from porcine lymph nodes and spleen.
Alvarez B; Martínez P; Yuste M; Poderoso T; Alonso F; Domínguez J; Ezquerra A; Revilla C
Dev Comp Immunol; 2014 May; 44(1):44-9. PubMed ID: 24291017
[TBL] [Abstract][Full Text] [Related]
10. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
Komohara Y; Ohnishi K; Takeya M
Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
Front Immunol; 2018; 9():1997. PubMed ID: 30237798
[TBL] [Abstract][Full Text] [Related]
12. A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Uchil PD; Pi R; Haugh KA; Ladinsky MS; Ventura JD; Barrett BS; Santiago ML; Bjorkman PJ; Kassiotis G; Sewald X; Mothes W
Cell Host Microbe; 2019 Jan; 25(1):87-100.e10. PubMed ID: 30595553
[TBL] [Abstract][Full Text] [Related]
13. CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity.
Lisk C; Yuen R; Kuniholm J; Antos D; Reiser ML; Wetzler LM
Front Immunol; 2021; 12():624197. PubMed ID: 33815376
[TBL] [Abstract][Full Text] [Related]
14. Tumor Necrosis Factor-Mediated Survival of CD169
Shinde PV; Xu HC; Maney SK; Kloetgen A; Namineni S; Zhuang Y; Honke N; Shaabani N; Bellora N; Doerrenberg M; Trilling M; Pozdeev VI; van Rooijen N; Scheu S; Pfeffer K; Crocker PR; Tanaka M; Duggimpudi S; Knolle P; Heikenwalder M; Ruland J; Mak TW; Brenner D; Pandyra AA; Hoell JI; Borkhardt A; Häussinger D; Lang KS; Lang PA
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142134
[TBL] [Abstract][Full Text] [Related]
15. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
[TBL] [Abstract][Full Text] [Related]
16. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
[TBL] [Abstract][Full Text] [Related]
17. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
[TBL] [Abstract][Full Text] [Related]
18. Growth of Murine Splenic Tissue Is Suppressed by Lymphotoxin β-Receptor Signaling (LTβR) Originating from Splenic and Non-Splenic Tissues.
Milićević NM; Nohroudi K; Schmidt F; Schmidt H; Ringer C; Sorensen GL; Milićević Ž; Westermann J
PLoS One; 2016; 11(12):e0166901. PubMed ID: 27936003
[TBL] [Abstract][Full Text] [Related]
19. Differential Roles of LTβR in Endothelial Cell Subsets for Lymph Node Organogenesis and Maturation.
Wang Z; Chai Q; Zhu M
J Immunol; 2018 Jul; 201(1):69-76. PubMed ID: 29760194
[TBL] [Abstract][Full Text] [Related]
20. Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.
Veninga H; Borg EG; Vreeman K; Taylor PR; Kalay H; van Kooyk Y; Kraal G; Martinez-Pomares L; den Haan JM
Eur J Immunol; 2015 Mar; 45(3):747-57. PubMed ID: 25487358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
